GlassScriptPhysician profile
Zofia Stec
NPI 1639567530
$2,482.05
in general payments reported to CMS, 2019-2025
13 companies · $1,058 in 2025
The $1,058 reported for 2025 was more than what 86% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $282 · 2022: $402 · 2023: $390 · 2024: $349 · 2025: $1,058.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,797.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $537.60 | 2021-2025 | Lifevest |
| Pfizer INC. | $449.51 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $326.63 | 2021-2025 | Wainua |
| Alnylam Pharmaceuticals INC. | $272.47 | 2025 | Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $269.77 | 2023-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $209.62 | 2021-2023 | Jardiance |
| Abbott Laboratories | $200.61 | 2022-2025 | Cardiomems |
| Novartis Pharmaceuticals Corporation | $59.27 | 2022-2024 | |
| Lexicon Pharmaceuticals, INC. | $42.67 | 2024 | |
| Janssen Pharmaceuticals, INC | $38.12 | 2022-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $29.93 | 2025 | |
| Merck Sharp & Dohme LLC | $25.98 | 2023 | Verquvo |
| Boston Scientific Corporation | $19.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zofia Stec listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.